Search - tctmd.com

Displaying 481 - 500 of 3013

Sort: Relevancy | Date

News Daily News

CT Angiography Is Increasing in England, but Downstream Tests Are Not

Michael O'Riordan

January 12, 2023

News Daily News

Routine Coronary Tests Prior to Kidney Transplant Questioned

Yael L. Maxwell

January 05, 2023

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for December 2022

Shelley Wood

January 03, 2023

News Opinion Conversations in Cardiology

Conversations in Cardiology: ISCHEMIA’s Lasting Fallout

December 29, 2022

News Daily News

Top Coronary Artery Disease News of 2022

Yael L. Maxwell

December 29, 2022

News Daily News

Anatomic Disease After PCI Linked With Worse Outcomes: VA CART

Michael O'Riordan

December 22, 2022

News Daily News

FFR Pullback Measure Linked to Likelihood of Angina Relief After PCI

Todd Neale

December 02, 2022

News Daily News

P2Y12 Inhibitors Top Aspirin Following Post-PCI DAPT: Network Meta-analysis

Todd Neale

November 21, 2022

News Daily News

Single-Center Study Offers Insights for Ticagrelor vs Prasugrel in Chronic CAD

Yael L. Maxwell

November 21, 2022

News Daily News

Many STEMI Patients Not Treated Within National Time Goals

Michael O'Riordan

November 15, 2022

News Conference News AHA 2022

Another OPTION? Indobufen Noninferior to Aspirin Following Successful PCI

Yael L. Maxwell

November 10, 2022

News Conference News AHA 2022

BRIGHT-4: Large, ‘Clean’ Trial Clarifies Bivalirudin Benefits in STEMI

Shelley Wood

November 06, 2022

News Daily News

Hospital Culture, Physician Preference Mostly Drive IVUS/OCT in PCI

L.A. McKeown

October 24, 2022

News Conference News TCT 2022

Late Catch-up Sours SUGAR for Polymer-Free Stent in Diabetic Patients

Yael L. Maxwell

September 27, 2022

News Conference News TCT 2022

Calcified Nodules Signal Worst Outcome Among OCT-Defined ACS Causes

Todd Neale

September 22, 2022

News Conference News TCT 2022

FAVOR III China: Early Gains of QFR in PCI Persist to 2 Years

L.A. McKeown

September 20, 2022

News Conference News TCT 2022

SCAAR Registry Delves Into Left Main Revascularization Outcomes

Michael O'Riordan

September 19, 2022

Presentation TCT 2022

Should We Be Stenting All Patients Presenting With STEMI? Pros and Cons

Presenter: Andrejs Erglis

September 19, 2022

Presentation TCT 2022

Two-Year Outcomes of the Randomized Second-Generation Drug-Eluting Stents in Diabetes (SUGAR) Trial

Presenter: Pablo Salinas

September 19, 2022

Presentation TCT 2022

TCT 167: Percutaneous Coronary Intervention with Ultrathin-Strut Biodegradable versus Thin-Strut Durable Polymer Drug-Eluting Stents of Lesions Requiring Multiple Stents: A Lesion-Level Subgroup Analysis of the Combined BIOSCIENCE and BIOSTEMI Randomized…

Presenter: Jonas Haener

September 19, 2022

Advertisement

CT Angiography Is Increasing in England, but Downstream Tests Are Not

Routine Coronary Tests Prior to Kidney Transplant Questioned

TCTMD’s Top 10 Most Popular Stories for December 2022

Conversations in Cardiology: ISCHEMIA’s Lasting Fallout

Top Coronary Artery Disease News of 2022

Anatomic Disease After PCI Linked With Worse Outcomes: VA CART

FFR Pullback Measure Linked to Likelihood of Angina Relief After PCI

P2Y12 Inhibitors Top Aspirin Following Post-PCI DAPT: Network Meta-analysis

Single-Center Study Offers Insights for Ticagrelor vs Prasugrel in Chronic CAD

Many STEMI Patients Not Treated Within National Time Goals

Another OPTION? Indobufen Noninferior to Aspirin Following Successful PCI

BRIGHT-4: Large, ‘Clean’ Trial Clarifies Bivalirudin Benefits in STEMI

Hospital Culture, Physician Preference Mostly Drive IVUS/OCT in PCI

Late Catch-up Sours SUGAR for Polymer-Free Stent in Diabetic Patients

Calcified Nodules Signal Worst Outcome Among OCT-Defined ACS Causes

FAVOR III China: Early Gains of QFR in PCI Persist to 2 Years

SCAAR Registry Delves Into Left Main Revascularization Outcomes

Should We Be Stenting All Patients Presenting With STEMI? Pros and Cons

Two-Year Outcomes of the Randomized Second-Generation Drug-Eluting Stents in Diabetes (SUGAR) Trial

TCT 167: Percutaneous Coronary Intervention with Ultrathin-Strut Biodegradable versus Thin-Strut Durable Polymer Drug-Eluting Stents of Lesions Requiring Multiple Stents: A Lesion-Level Subgroup Analysis of the Combined BIOSCIENCE and BIOSTEMI Randomized…

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content